Cargando…

Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers

PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp...

Descripción completa

Detalles Bibliográficos
Autores principales: Phung, Lam, Lollett, Ivonne V., Goldhardt, Raquel, Davis, Janet L., Young, Larry, Ascherman, Dana, Galor, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731714/
https://www.ncbi.nlm.nih.gov/pubmed/29260117
http://dx.doi.org/10.1016/j.ajoc.2017.10.008
_version_ 1783286553241452544
author Phung, Lam
Lollett, Ivonne V.
Goldhardt, Raquel
Davis, Janet L.
Young, Larry
Ascherman, Dana
Galor, Anat
author_facet Phung, Lam
Lollett, Ivonne V.
Goldhardt, Raquel
Davis, Janet L.
Young, Larry
Ascherman, Dana
Galor, Anat
author_sort Phung, Lam
collection PubMed
description PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp examination revealed punctate epithelial erosions, decreased tear break-up time, and decreased tear lake bilaterally. Initial tests for ocular surface inflammation (InflammaDry, Quidel, San Diego) and systemic autoantibodies (antinuclear antibodies, anti-SSA/Ro and anti-SSB/La) were negative. After 4 months of persistent ocular symptoms and signs, ocular surface inflammation was detected via InflammaDry and blood results included a positive antinuclear antibody (1:160), rheumatoid factor (IgG 25.3 EU/ml), and carbonic anhydrase 6 (IgM 20.2 EU/ml), but persistently negative anti-SSA/Ro and anti-SSB/La antibodies. CONCLUSIONS AND IMPORTANCE: Taken together, these findings were suggestive of early Sjogren's syndrome with simultaneous appearance of both ocular and serum biomarkers. Novel autoantibodies testing in suspected patients can guide early intervention and potentially improve both the glandular and extra-glandular function in patients.
format Online
Article
Text
id pubmed-5731714
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57317142017-12-19 Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers Phung, Lam Lollett, Ivonne V. Goldhardt, Raquel Davis, Janet L. Young, Larry Ascherman, Dana Galor, Anat Am J Ophthalmol Case Rep Case report PURPOSE: To report on a case of a young female with progressing dry eye symptoms and evolving autoimmune markers consistent with a presentation of early Sjogren's syndrome (SS). OBSERVATIONS: A 32 year-old female presented with chronic dry eye symptoms refractory to artificial tears. Slit lamp examination revealed punctate epithelial erosions, decreased tear break-up time, and decreased tear lake bilaterally. Initial tests for ocular surface inflammation (InflammaDry, Quidel, San Diego) and systemic autoantibodies (antinuclear antibodies, anti-SSA/Ro and anti-SSB/La) were negative. After 4 months of persistent ocular symptoms and signs, ocular surface inflammation was detected via InflammaDry and blood results included a positive antinuclear antibody (1:160), rheumatoid factor (IgG 25.3 EU/ml), and carbonic anhydrase 6 (IgM 20.2 EU/ml), but persistently negative anti-SSA/Ro and anti-SSB/La antibodies. CONCLUSIONS AND IMPORTANCE: Taken together, these findings were suggestive of early Sjogren's syndrome with simultaneous appearance of both ocular and serum biomarkers. Novel autoantibodies testing in suspected patients can guide early intervention and potentially improve both the glandular and extra-glandular function in patients. Elsevier 2017-10-06 /pmc/articles/PMC5731714/ /pubmed/29260117 http://dx.doi.org/10.1016/j.ajoc.2017.10.008 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case report
Phung, Lam
Lollett, Ivonne V.
Goldhardt, Raquel
Davis, Janet L.
Young, Larry
Ascherman, Dana
Galor, Anat
Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title_full Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title_fullStr Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title_full_unstemmed Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title_short Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers
title_sort parallel ocular and serologic course in a patient with early sjogren's syndrome markers
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731714/
https://www.ncbi.nlm.nih.gov/pubmed/29260117
http://dx.doi.org/10.1016/j.ajoc.2017.10.008
work_keys_str_mv AT phunglam parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT lollettivonnev parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT goldhardtraquel parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT davisjanetl parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT younglarry parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT aschermandana parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers
AT galoranat parallelocularandserologiccourseinapatientwithearlysjogrenssyndromemarkers